home > drugs a-z list > isentress (raltegravir tablets) drug center

Recommended Topic Related To:

Isentress

Entry Inhibitors (including Fusion Inhibitors) and CCR5 Co-receptor Antagonist

Entry Inhibitors
Entry inhibitors block HIV entry into CD4+ cells.

Fusion inhibitors
The only drug in this class is T-20, which is administered as a twice daily subcutaneous injection. The most common side effect is redness and pain at the site of injection. Rarely, infection can occur at the injection site. There also are reports of generalized allergic reactions.

CCR5 antagonist
Although there were some early concerns of liver inflammation for drugs in this class, MVC appeared to be well tolerated in clinical trials without any specific toxicities attributable to the drug. However, it is a new drug in a new class and the first to actually target the cell. For these reasons, longer follow-up from clinical trials and those followed in the clinic will be very important for assessing the overall safety of the...

Isentress

font size

Isentress Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Isentress Prescribing Information: Indications & Dosage

ISENTRESS® (raltegravir) Structural Formula Illustration

Adults

ISENTRESS® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection.

This indication is based on analyses of plasma HIV-1 RNA levels in three double-blind controlled studies of ISENTRESS. Two of these studies were conducted in clinically advanced, 3-class antiretroviral (NNRTI, NRTI, PI) treatment-experienced adults through 96 weeks and one was conducted in treatment-naïve adults through 156 weeks.

The use of other active agents with ISENTRESS is associated with a greater lik...

Read the complete drug monograph for Isentress »

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Isentress Patient Information: Side Effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

  • pale skin, easy bruising or bleeding;
  • signs of a new infection, such as fever or chills, cough, or flu symptoms;
  • sore throat and headache with a severe blistering, peeling, and red skin rash;
  • drowsiness, confusion, increased thirst, lower back pain, urinating less than usual or not at all;
  • depr...

Read the complete patient information for Isentress »

What is Consumer information?

A concise overview of the drug for the patient or caregiver from First DataBank.

Isentress Consumer Information: Uses

Raltegravir is used with other medications to help control your HIV infection, thereby improving your quality of life. It also lowers your risk of getting complications from HIV (e.g., new infections, cancer). This medication is usually prescribed to people who have taken other HIV medications that did not work well enough to control their HIV. Raltegravir is known as an integrase inhibitor. It blocks the virus from growing and infecting more cells.

Raltegravir is not a cure for HIV, and it does not prevent the spread of HIV to others through sexual contact or blood contamination (e.g., sha...

Read the complete consumer information for Isentress »

What is Isentress Consumer Information?

Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More

Isentress - User Reviews

Isentress User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Isentress sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


WebMD Daily

Get breaking medical news.